Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Laine

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Sairaanhoitaja. Sjukskoterskan|December 13, 1971
[Paihola psychiatric hospitals]M Apo, I Laine
Expert Opinion on Therapeutic Patents|March 9, 2010
Inhibitors of cathepsin C (dipeptidyl peptidase I)Dramane I Laine, Jakob Busch-Petersen
Revue D'Epidemiologie Et De Sante Publique|April 24, 1999
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]B Grandbastien, C Gower-Rousseau, V Merle, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPDZehong Wan, Dramane I Laine, Hongxing Yan, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activityRichard Angell, Nicola M Aston, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2008
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modesRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl aminesBrian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Sairaanhoitaja. Sjukskoterskan|December 13, 1971
[Paihola psychiatric hospitals]M Apo, I Laine
Expert Opinion on Therapeutic Patents|March 9, 2010
Inhibitors of cathepsin C (dipeptidyl peptidase I)Dramane I Laine, Jakob Busch-Petersen
Revue D'Epidemiologie Et De Sante Publique|April 24, 1999
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]B Grandbastien, C Gower-Rousseau, V Merle, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPDZehong Wan, Dramane I Laine, Hongxing Yan, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activityRichard Angell, Nicola M Aston, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2008
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modesRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl aminesBrian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Pageof 1